HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Song Han Selected Research

Kv1.3 Potassium Channel

11/2020Blockade of Kv1.3 potassium channel inhibits CD8+ T cell-mediated neuroinflammation via PD-1/Blimp-1 signaling.
7/2012Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilus tricostatus.
9/2008Characterization of a new Kv1.3 channel-specific blocker, J123, from the scorpion Buthus martensii Karsch.
7/2008Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Song Han Research Topics

Disease

42Neoplasms (Cancer)
01/2022 - 02/2004
18Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2022 - 01/2012
17Ischemic Stroke
10/2022 - 10/2013
15Infarction (Infarctions)
01/2020 - 05/2011
14Hypoxia (Hypoxemia)
12/2019 - 08/2005
13Wounds and Injuries (Trauma)
09/2021 - 05/2011
11Inflammation (Inflammations)
12/2021 - 06/2008
10Infections
01/2021 - 05/2014
10Glioma (Gliomas)
01/2021 - 06/2013
10Ischemia
08/2020 - 12/2007
8Pancreatic Neoplasms (Pancreatic Cancer)
02/2020 - 12/2015
7Stroke (Strokes)
10/2022 - 10/2015
7Brain Ischemia (Cerebral Ischemia)
01/2022 - 03/2012
7Epilepsy (Aura)
10/2021 - 01/2013
6Breast Neoplasms (Breast Cancer)
01/2022 - 12/2011
6Autoimmune Diseases (Autoimmune Disease)
11/2020 - 07/2008
5Neoplasm Metastasis (Metastasis)
01/2022 - 04/2016
4Neuroinflammatory Diseases
12/2021 - 01/2017
4Body Weight (Weight, Body)
02/2021 - 07/2009
4Pain (Aches)
01/2021 - 10/2009
4Hyperalgesia
10/2020 - 10/2009
4Brain Injuries (Brain Injury)
06/2018 - 05/2011
4Seizures (Absence Seizure)
01/2018 - 10/2013
4Pancreatitis
01/2017 - 07/2013
3Adenocarcinoma
01/2022 - 01/2013
3Diabetes Mellitus
01/2022 - 09/2014
3Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2017
3Carcinogenesis
01/2022 - 01/2017
3Febrile Seizures (Febrile Seizure)
10/2018 - 08/2015
3Hyperthermia
11/2017 - 10/2013
3Fibrosis (Cirrhosis)
10/2015 - 07/2013
3Edema (Dropsy)
09/2014 - 01/2012
2Demyelinating Diseases (Demyelinating Disease)
10/2022 - 01/2021
2Myopia
07/2022 - 07/2022
2Kidney Neoplasms (Kidney Cancer)
01/2022 - 01/2016
2Obesity
01/2022 - 08/2008
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2021 - 08/2012
2Status Epilepticus (Complex Partial Status Epilepticus)
10/2021 - 01/2021
2Hemorrhage
09/2021 - 07/2020
2Carcinoma (Carcinomatosis)
01/2021 - 01/2013
2Brain Neoplasms (Brain Tumor)
01/2021 - 03/2014

Drug/Important Bio-Agent (IBA)

40Proteins (Proteins, Gene)FDA Link
10/2022 - 08/2005
17Oxygen (Dioxygen)IBA
10/2022 - 02/2012
16Glucose (Dextrose)FDA LinkGeneric
10/2022 - 10/2013
11MicroRNAs (MicroRNA)IBA
02/2020 - 03/2012
10Messenger RNA (mRNA)IBA
10/2020 - 08/2007
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2011
7Pharmaceutical PreparationsIBA
01/2021 - 02/2011
7Protein Kinase CIBA
01/2018 - 06/2006
7ApelinIBA
01/2017 - 08/2007
6Biomarkers (Surrogate Marker)IBA
04/2021 - 01/2018
6CytokinesIBA
01/2021 - 11/2008
6Peptides (Polypeptides)IBA
01/2019 - 07/2008
5LigandsIBA
01/2022 - 01/2013
5RNA (Ribonucleic Acid)IBA
01/2022 - 02/2004
5Long Noncoding RNAIBA
01/2021 - 01/2017
4Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
05/2021 - 11/2017
4Kv1.3 Potassium ChannelIBA
11/2020 - 07/2008
4Interleukin-17 (Interleukin 17)IBA
01/2020 - 06/2017
4InterleukinsIBA
02/2019 - 10/2016
4Biological ProductsIBA
01/2019 - 01/2017
4Protein Isoforms (Isoforms)IBA
01/2018 - 06/2006
3Crystallins (Crystallin)IBA
01/2022 - 12/2011
3Sitagliptin Phosphate (Januvia)FDA Link
05/2021 - 01/2017
3Immune Checkpoint InhibitorsIBA
04/2021 - 12/2020
3InterferonsIBA
01/2021 - 12/2015
3Morphine (MS Contin)FDA LinkGeneric
01/2021 - 04/2013
3Therapeutic UsesIBA
01/2021 - 08/2014
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 01/2013
3salicylhydroxamic acid (SHAM)IBA
10/2020 - 08/2013
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2020 - 08/2007
3Caspase 3 (Caspase-3)IBA
01/2020 - 11/2015
3Conditioned Culture MediaIBA
12/2019 - 01/2017
3vitexinIBA
06/2018 - 12/2015
3Remifentanil (Ultiva)FDA Link
01/2018 - 10/2009
3Small Interfering RNA (siRNA)IBA
12/2017 - 09/2012
3Propofol (Diprivan)FDA LinkGeneric
01/2017 - 10/2009
3Beclin-1IBA
12/2016 - 07/2014
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2016 - 11/2012
3p38 Mitogen-Activated Protein KinasesIBA
03/2013 - 08/2007
2Macular PigmentIBA
07/2022 - 07/2022
2ZeaxanthinsIBA
07/2022 - 07/2022
2VaccinesIBA
01/2022 - 05/2014
2Lysine (L-Lysine)FDA Link
01/2022 - 11/2017
2Histones (Histone)IBA
01/2022 - 11/2017
2InflammasomesIBA
12/2021 - 01/2020
2Saline SolutionIBA
10/2021 - 01/2017
2Dipeptidyl-Peptidase IV InhibitorsIBA
05/2021 - 01/2017
2Kainic Acid (Kainate)IBA
05/2021 - 10/2013
2DNA (Deoxyribonucleic Acid)IBA
04/2021 - 02/2004
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2021 - 01/2020
2Blood Glucose (Blood Sugar)IBA
02/2021 - 01/2016
2Analgesics (Analgesic Drugs)IBA
01/2021 - 10/2020
2Caveolin 1IBA
01/2021 - 10/2020
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2021

Therapy/Procedure

25Therapeutics
10/2022 - 07/2008
3Induced Hyperthermia (Thermotherapy)
01/2017 - 10/2013
3Ligation
12/2015 - 09/2014
2Immunotherapy
01/2021 - 12/2020
2Drug Therapy (Chemotherapy)
01/2021 - 01/2011